血管紧张素转换酶抑制对原发性高血压患者血压、血浆肾素活性及血浆醛固酮的影响。 - Suppr

Suppr

超能文献

Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.

作者信息

Gavras H, Gavras I, Textor S, Volicer L, Brunner H R, Rucinska E J

出版信息

J Clin Endocrinol Metab. 1978 Feb;46(2):220-6. doi: 10.1210/jcem-46-2-220.

DOI:10.1210/jcem-46-2-220

PMID:220274

Abstract

摘要

相似文献

Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.血管紧张素转换酶抑制对原发性高血压患者血压、血浆肾素活性及血浆醛固酮的影响。

J Clin Endocrinol Metab. 1978 Feb;46(2):220-6. doi: 10.1210/jcem-46-2-220.

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.替普罗肽抑制转化酶期间的激素及血压变化

Postgrad Med J. 1981 May;57(667):283-8. doi: 10.1136/pgmj.57.667.283.

Angiotensin inhibitors for hypertension.用于治疗高血压的血管紧张素抑制剂

Compr Ther. 1980 May;6(5):14-8.

The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients.转化酶抑制剂SQ 20.881对高血压患者激肽、肾素-血管紧张素-醛固酮及儿茶酚胺与血压关系的影响。

Acta Med Scand. 1978;204(6):497-502. doi: 10.1111/j.0954-6820.1978.tb08479.x.

The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertension.血管紧张素转换酶抑制剂在高血压诊断与治疗中的应用。

Clin Sci Mol Med Suppl. 1975 Jun;2:57s-60s. doi: 10.1042/cs048057s.

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.一种用于识别和治疗高血压患者血管收缩和容量因素的血管紧张素转换酶抑制剂。

N Engl J Med. 1974 Oct 17;291(16):817-21. doi: 10.1056/NEJM197410172911603.

Angiotensin-converting enzyme inhibitors.血管紧张素转换酶抑制剂

Am Fam Physician. 1980 Nov;22(5):164-5.

Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.肾素-钠分析及转化酶抑制所提示的肾素在高血压中的可能作用。

N Engl J Med. 1977 Mar 24;296(12):641-6. doi: 10.1056/NEJM197703242961201.

Effects of angiotensin converting enzyme inhibitor and angiotensin II analogue on hypertension. Study of hypertension with two different blockers of the renin-angiotensin-aldosterone system.血管紧张素转换酶抑制剂和血管紧张素II类似物对高血压的影响。使用两种不同的肾素-血管紧张素-醛固酮系统阻滞剂对高血压的研究。

Nihon Jinzo Gakkai Shi. 1985 Mar;27(3):353-61.

[Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].口服血管紧张素I转换酶抑制剂治疗高血压患者的临床经验：单次剂量对血压及肾素-醛固酮系统的影响（作者译）

Nihon Jinzo Gakkai Shi. 1980 Jan;22(1):1-11.

引用本文的文献

Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study.联合他汀类药物和 ACE 抑制剂治疗对原发性高血压患者内皮功能和血压的影响：一项随机、双盲、安慰剂对照交叉研究。

J Renin Angiotensin Aldosterone Syst. 2019 Jul-Sep;20(3):1470320319868890. doi: 10.1177/1470320319868890.

Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).肾素血管紧张素系统的进展集中在血管紧张素转换酶2和血管紧张素-（1-7）上。

Adv Pharmacol. 2010;59:197-233. doi: 10.1016/S1054-3589(10)59007-0.

Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.依那普利对原发性高血压患者的利钠作用及肾血流动力学变化

Drugs. 1985;30 Suppl 1:49-58. doi: 10.2165/00003495-198500301-00008.

The adrenal receptor for angiotensin II is altered in essential hypertension.原发性高血压患者体内的血管紧张素 II 肾上腺受体发生了改变。

J Clin Invest. 1979 Mar;63(3):419-27. doi: 10.1172/JCI109318.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验